Sequella, Inc.

ROCKVILLE, MD · Aerospace · Private

Environmental Mapping Autonomous free-flyer Payload (EMAP) Module — a multi-sensor hardware module for robotic platforms that monitors acoustic noise, air quality, and thermal imaging via integrated s

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · sequella.com

Sector: Aerospace
Headquarters: ROCKVILLE, MD
Latest Form D: $631K, Oct 2017
Total capital: $13.1M

Federal grants: $125K; 1 award · 2018; Rank in peer group#23 of 187
Private capital raised: $12.9M; 12 Form D · last Oct 2017; 109 months since last filing
Federal contracts: $119K; 1 award · Health and Human S; Rank in Aerospace#680 of 1335
Granted patents: 0; 6 pending

Capital timeline

Latest events

Jul 2018Federal grantNASA · Phase I · Environmental Mapping Payload Module for Astrobee$125K
Oct 2017Private capital raisedForm D · SEC · 12th filing$631K
Sep 2016Private capital raisedForm D · SEC · 11th filing$941K
Sep 2016Private capital raisedForm D · SEC · 10th filing$1.7M
Oct 2014Private capital raisedForm D · SEC · 9th filing$3.1M
Oct 2013Private capital raisedForm D · SEC · 8th filing$555K
Sep 2012Private capital raisedForm D · SEC · 7th filing$100K
Nov 2011Private capital raisedForm D · SEC · 6th filing$50K
Aug 2011Private capital raisedForm D · SEC · 5th filing$550K
Jun 2011Private capital raisedForm D · SEC · 4th filing$1M
Feb 2010Private capital raisedForm D · SEC · 3rd filing$2M
Aug 2009Private capital raisedForm D · SEC · 2nd filing$1.5M
Jul 2009Private capital raisedForm D · SEC · 1st filing$720K

Show 1 earlier federal award

Dec 2007Federal contractHealth and Human S · NIAAA-08-01, Sequella, Inc., Pop 5/1/07 - 06/30/2008 Phase Iithis Is The Revised Period Of Performance For This SBIR Phase II Contract (N44AA33009) Not Converted In Nbs$119K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

19months

from Sequella, Inc.’s first federal award to its first private round.

First federal award · Dec 2007: Health and Human S · $119K
First Form D · Jul 2009: $720K · 1st Form D
Awards before first raise: 1 award

An association in public records, not a cause or a prediction.

Standing among 187 peers

Line = median

Aerospace · Device

Federal grants#23 · top 12%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings

Alan KleinExecutive OfficerNamed in SEC Form D filings
Bradley I RotterDirectorNamed in SEC Form D filings
Carol A NacyExecutive Officer, DirectorNamed in SEC Form D filings
DAVID I. MCNEELEYExecutive OfficerNamed in SEC Form D filings
Gary HorwithExecutive OfficerNamed in SEC Form D filings
John M FriedmanDirectorNamed in SEC Form D filings

Show all 14 people

Kenneth I. LynnDirectorNamed in SEC Form D filings
LAWRENCE I. MILLERExecutive OfficerNamed in SEC Form D filings
Leo A EinckExecutive Officer, DirectorNamed in SEC Form D filings
MARK I. RAMPYExecutive OfficerNamed in SEC Form D filings
Martin M ZugExecutive OfficerNamed in SEC Form D filings
Paige I. MacDonaldDirectorNamed in SEC Form D filings
Ronald I MeltzerDirectorNamed in SEC Form D filings
William HoskinsDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 6

PendingImproved Methods And Compositions For Determining The Pathogenic Status Of Infectious AgentsUSPTOApplication PCTUS2011022161
PendingCompositions And Methods Comprising Capuramycin AnaloguesUSPTOApplication PCTUS2008086224
PendingImproved Methods And Compositions For Determining The Pathogenic Status Of Infectious AgentsUSPTOApplication PCTUS2008004491

Show all 6 patent records

Improved Methods And Compositions For Determining The Pathogenic Status Of Infectious AgentsApplication PCTUS2011022161Pending
Compositions And Methods Comprising Capuramycin AnaloguesApplication PCTUS2008086224Pending
Improved Methods And Compositions For Determining The Pathogenic Status Of Infectious AgentsApplication PCTUS2008004491Pending
Anti-tubercular Drugs: Compositions And MethodsApplication PCTUS2006026078Pending
Methods And Compositions Comprising Diamines As New Anti-tubercular TherapeuticsApplication PCTUS2004029284Pending
Methods Of Use And Compositions For The Diagnosis And Treatment Of Infectious DiseaseApplication PCTUS2003015925Pending

PARTICLE MATTERS, INCSimilar federal contract value in Aerospace · $123K in contracts
Assurance Technology CorporationSimilar federal contract value in Aerospace · $121K in contracts
Planck Aerosystems IncSimilar federal contract value in Aerospace · $121K in contracts
MOMENTUM OPTICS INCSimilar federal contract value in Aerospace · $117K in contracts
VISSIDUS TECHNOLOGIES INCSimilar federal contract value in Aerospace · $116K in contracts
NEW DAWN LABS LLCSimilar federal contract value in Aerospace · $111K in contracts

Regulatory activity · Aerospace

Sector-level, not company-level

06 Jul 2026Nondiscrimination in Federally Assisted Programs of NASA-Effectuation of Title VI of the Civil Rights Act of 1964National Aeronautics and Space Administration
01 Jul 2026Special Conditions: AMAC Aerospace, The Boeing Company Model 747- 8 Airplane; Side-Facing SeatsFederal Aviation Administration
26 Jun 2026Standard Instrument Approach Procedures, and Takeoff Minimums and Obstacle Departure Procedures; Miscellaneous AmendmentsFederal Aviation Administration
23 Jun 2026Operating Limitations at John F. Kennedy International AirportFederal Aviation Administration
23 Jun 2026Operating Limitations at New York LaGuardia AirportFederal Aviation Administration
18 Jun 2026Special Conditions: Honeywell Aerospace US LLC, Dassault Aviation Model Falcon 900EX Airplane; Electronic System Security Protection From Unauthorized External AccessFederal Aviation Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.